The Italian Society of Cardiology and Working Group on Telecardiology and Informatics 2023 updated position paper on telemedicine and artificial intelligence in cardiovascular disease.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
medline:
17
5
2023
pubmed:
15
5
2023
entrez:
15
5
2023
Statut:
ppublish
Résumé
In 2015, the Italian Society of Cardiology and its Working Group on Telemedicine and Informatics issued a position paper on Telecardiology, resuming the most eminent evidence supporting the use of information and communication technology in principal areas of cardiovascular care, ranked by level of evidence. More than 5 years later and after the global shock inflicted by the SARS-CoV-2 pandemic, an update on the topic is warranted. Recent evidence and studies on principal areas of cardiovascular disease will be therefore reported and discussed, with particular focus on telemedicine for cardiovascular care in the COVID-19 context. Novel perspectives and opportunities disclosed by artificial intelligence and its applications in cardiovascular disease will also be discussed. Finally, modalities by which machine learning have realized remote patient monitoring and long-term care in recent years, mainly filtering critical clinical data requiring selective hospital admission, will be provided.
Identifiants
pubmed: 37186567
doi: 10.2459/JCM.0000000000001447
pii: 01244665-202305002-00009
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e168-e177Informations de copyright
Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Brunetti ND, Scalvini S, Acquistapace F, et al. Telemedicine for cardiovascular disease continuum: a position paper from the Italian Society of Cardiology Working Group on Telecardiology and Informatics. Int J Cardiol 2015; 184:452–458.
Beygui F, Castren M, Brunetti ND, et al. ACCA Study Group on Prehospital Care. Prehospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC. Eur Heart J Acute Cardiovasc Care 2020; 9: (1_Suppl): 59–81.
Curcio A, Spaccarotella C, Brunetti ND, et al. Italian Society of Cardiology (SIC) position paper: technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine. G Ital Cardiol (Rome) 2021; 22:1017–1023.
Brunetti ND, Di Pietro G, Aquilino A, et al. Prehospital electrocardiogram triage with tele-cardiology support is associated with shorter time-to-balloon and higher rates of timely reperfusion even in rural areas: data from the Bari- Barletta/Andria/Trani public emergency medical service 118 registry on primary angioplasty in ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 2014; 3:204–213.
Kawakami S, Tahara Y, Noguchi T, et al. Time to reperfusion in ST-segment elevation myocardial infarction patients with vs. without pre-hospital mobile telemedicine 12-lead electrocardiogram transmission. Circ J 2016; 80:1624–1633.
Brunetti ND, Dell’Anno A, Martone A, et al. Prehospital ECG transmission results in shorter door-to-wire time for STEMI patients in a remote mountainous region. Am J Emerg Med 2020; 38:252–257.
Brunetti ND, De Gennaro L, Correale M, et al. Prehospital electrocardiogram triage with telemedicine near halves time to treatment in STEMI: a meta-analysis and meta-regression analysis of nonrandomized studies. Int J Cardiol 2017; 232:5–11.
Nakashima T, Hashiba K, Kikuchi M, et al. Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee. Impact of prehospital 12-lead electrocardiography and destination hospital notification on mortality in patients with chest pain – a systematic review. Circ Rep 2022; 4:187–193.
Marcolino MS, Maia LM, Oliveira JAQ, et al. Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis. Heart 2019; 105:1479–1486.
Papai G, Csato G, Racz I, et al. The transtelephonic electrocardiogram-based triage is an independent predictor of decreased hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Telemed Telecare 2020; 26:216–222.
Brunetti ND, Bisceglia L, Dellegrottaglie G, et al. Lower mortality with prehospital electrocardiogram triage by telemedicine support in high risk acute myocardial infarction treated with primary angioplasty: preliminary data from the Bari-BAT public Emergency Medical Service 118 registry. Int J Cardiol 2015; 185:224–228.
Brunetti ND, Molinari G, Acquistapace F, et al. 2019 Italian Society of Cardiology Census on telemedicine in cardiovascular disease: a report from the working group on telecardiology and informatics. Open Heart 2020; 7:e001157.
Lumley HA, Flynn D, Shaw L, et al. A scoping review of prehospital technology to assist ambulance personnel with patient diagnosis or stratification during the emergency assessment of suspected stroke. BMC Emerg Med 2020; 20:30.
Scalvini S, Zanelli E, Conti C, et al. Assessment of prehospital chest pain using telecardiology. J Telemed Telecare 2002; 8:231–236.
Molinari G, Reboa G, Frascio M, et al. The role of telecardiology in supporting the decision-making process of general practitioners during the management of patients with suspected cardiac events. J Telemed Telecare 2002; 8:97–101.
Gruska M, Aigner G, Altenberger J, et al. Recommendations on the utilization of telemedicine in cardiology. Wien Klin Wochenschr 2020; 132:782–800.
Lin MH, Yuan WL, Huang TC, Zhang HF, Mai JT, Wang JF. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. J Investig Med 2017; 65:899–911.
Brahmbhatt DH, Cowie MR. Remote management of heart failure: an overview of telemonitoring technologies. Card Fail Rev 2019; 24:86–92.
Scalvini S, Zanelli E, Paletta L, et al. Chronic heart failure home-based management with a telecardiology system: a comparison between patients followed by general practitioners and by a cardiology department. J Telemed Telecare 2006; 12:S46–S48.
Molinari G, Molinari M, Di Biase M, Brunetti ND. Telecardiology and its settings of application: an update. J Telemed Telecare 2018; 24:373–381.
Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012; 125:2985–2992.
De Simone A, Leoni L, Luzi M, et al. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace 2015; 17:12671275.
Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB. CHAMPION Trial Study Group. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 2016; 387:453–461.
Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005; 45:1654–1664.
Klersy C, De Silvestri A, Gabutti G, et al. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009; 54:1683–1694.
Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363:2301–2309.
Ferrante D, Varini S, Macchia A, et al. Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up. J Am Coll Cardiol 2010; 56:372–378.
Koehler F, Winkler S, Schieber M, et al. Telemedical Interventional Monitoring in Heart Failure Investigators. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation 2011; 123:1873–1880.
Angermann CE, Störk S, Gelbrich G, et al. Competence Network Heart Failure. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 2012; 5:25–35.
Ong MK, Romano PS, Edgington S, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition – heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med 2016; 176:310–318.
Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or noninvasive telemonitoring for patients with heart failure. Heart 2017; 103:255–257.
Koehler F, Koehler K, Deckwart O, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet 2018; 22:1047–1057.
Galinier M, Roubille F, Berdague P, et al. Telemonitoring versus standard care in heart failure: a randomised multicentre trial. Eur J Heart Fail 2020; 22:985–994.
Clark RA, Conway A, Poulsen V, Keech W, Tirimacco R, Tideman P. Alternative models of cardiac rehabilitation: a systematic review. Eur J Prev Cardiol 2015; 22:35–74.
Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R. Telehealth exercise-based cardiac rehabilitation: a systematic review and meta-analysis. Heart 2016; 102:1183–1192.
Dalal HM, Taylor RS. Telehealth technologies could improve suboptimal rates of participation in cardiac rehabilitation. Heart 2016; 102:1155–1156.
Brouwers RWM, van Exel HJ, van Hal JMC, et al. Cardiac telerehabilitation as an alternative to centre-based cardiac rehabilitation. Neth Heart J 2020; 28:443–451.
Frederix I, Hansen D, Coninx K, et al. Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: a cost-effectiveness analysis. Eur J Prev Cardiol 2016; 23:674–682.
Maddison R, Rawstorn JC, Stewart RAH, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled noninferiority trial. Heart 2019; 105:122–129.
Jin K, Khonsari S, Gallagher R, et al. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review and meta-analysis. Eur J Cardiovasc Nurs 2019; 18:260–271.
Dubner S, Auricchio A, Steinberg JS, et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17:36–56.
Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021; 42:3427–3520.
Versteeg H, Pedersen SS, Mastenbroek MH, et al. Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study. Neth Heart J 2014; 22:423–428.
Guédon-Moreau L, Kouakam C, Klug D, et al. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol 2014; 25:763–770.
Pron G, Ieraci L, Kaulback K. Medical Advisory Secretariat, Health Quality Ontario. Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis. Ont Health Technol Assess Ser 2012; 12:1–86.
Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol 2015; 65:2591–2600.
Hindricks G, Varma N, Kacet S, et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J 2017; 38:1749–1755.
Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GY, Blomstrom-Lundqvist C. Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 2014; 16:129–132.
Health Quality Ontario. Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment. Ont Health Technol Assess Ser 2018; 18:1–199.
Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122:325–332.
Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH. CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011; 57:1181–1189.
Guédon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34:605–614.
Ganeshan R, Enriquez AD, Freeman JV. Remote monitoring of implantable cardiac devices: current state and future directions. Curr Opin Cardiol 2018; 33:20–30.
Sapp JA, Gillis AM, AbdelWahab A, et al. Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study. CMAJ Open 2021; 9:E53–E61.
Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17:1601–1687.
Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10:707–725.
Drak-Hernández Y, Toquero-Ramos J, Fernández JM, Pérez-Pereira E, Castro-Urda V, Fernández-Lozano I. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed) 2013; 66:943–948.
Li K, White F, Tipoe T, et al. The current state of mobile phone apps for monitoring heart rate, heart rate variability, and atrial fibrillation: narrative review. JMIR Mhealth Uhealth 2019; 7:e11606.
Bayoumy K, Gaber M, Elshafeey A, et al. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat Rev Cardiol 2021; 18:581–599.
Dagher L, Shi H, Zhao Y, Marrouche NF. Wearables in cardiology: here to stay. Heart Rhythm 2020; 17:889–895.
Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019; 381:1909–1917.
MacKinnon GE, Brittain EL. Mobile health technologies in cardiopulmonary disease. Chest 2020; 157:654–664.
Guo Y, Lane DA, Wang L, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol 2020; 75:1523–1534.
Masterson Creber RM, Reading Turchioe M, Biviano A, et al. Cardiac symptom burden and arrhythmia recurrence drives digital health use: results from the iHEART randomized controlled trial. Eur J Cardiovasc Nurs 2022; 21:107–115.
De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020; 41:2083–2088.
Ghilencea LN, Chiru MR, Stolcova M, et al. Telemedicine: benefits for cardiovascular patients in the COVID-19 era. Front Cardiovasc Med 2022; 9:868635.
Katz JN, Sinha SS, Alviar CL, et al. COVID-19 and disruptive modifications to cardiac critical care delivery: JACC review topic of the week. J Am Coll Cardiol 2020; 76:72–84.
Tersalvi G, Winterton D, Cioffi GM, et al. Telemedicine in heart failure during COVID-19: a step into the future. Front Cardiovasc Med 2020; 7:612818.
Patel P, Dhindsa D, Eapen DJ, et al. Optimizing the potential for telehealth in cardiovascular care (in the era of COVID-19): time will tell. Am J Med 2021; 134:945–951.
Seltzer J, Senatore F, Faulkner K, et al. The COVID-19 pandemic and cardiovascular issues in clinical trials: practical and regulatory issues in remote monitoring of cardiac safety. Am Heart J 2022; 243:122–126.
Curcio A, De Rosa S, Sabatino J, et al. Clinical usefulness of a mobile application for the appropriate selection of the antiarrhythmic device in heart failure. Pacing Clin Electrophysiol 2016; 39:696–702.
Pluymaekers NAHA, Hermans ANL, van der Velden RMJ, et al. Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. Europace 2021; 23:345–352.
Spaccarotella CAM, Polimeni A, Migliarino S, et al. Multichannel electrocardiograms obtained by a smartwatch for the diagnosis of ST-segment changes. JAMA Cardiol 2020; 5:1176–1180.
Beyhoff N, Zhu M, Zanders L, et al. Teleproctoring for training in structural heart interventions: initial real-world experience during the COVID-19 pandemic. J Am Heart Assoc 2022; 11:e023757.
Goel SS, Greenbaum AB, Patel A, et al. Role of teleproctoring in challenging and innovative structural interventions amid the COVID-19 pandemic and beyond. JACC Cardiovasc Interv 2020; 13:1945–1948.
Bini SA. Artificial intelligence, machine learning, deep learning, and cognitive computing: what do these terms mean and how will they impact healthcare? J Arthroplasty 2018; 33:2358–2361.
Al’Aref SJ, Anchouche K, Singh G, et al. Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging. Eur Heart J 2019; 40:1975–1986.
Hannun AY, Rajpurkar P, Haghpanahi M, et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med 2019; 25:65–69.
Knackstedt C, Bekkers SC, Schummers G, et al. Fully automated versus standard tracking of left ventricular ejection fraction and longitudinal strain: the FAST-EFs multicenter study. J Am Coll Cardiol 2015; 66:1456–1466.
O’Brien H, Whitaker J, Singh Sidhu B, et al. Automated left ventricle ischemic scar detection in CCT using deep neural networks. Front Cardiovasc Med 2021; 8:655252.
Motwani M, Dey D, Berman DS, Germano G, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J 2017; 38:500–507.
Winther HB, Hundt C, Schmidt B, et al. v-net: deep learning for generalized biventricular mass and function parameters using multicenter cardiac MRI data. JACC Cardiovasc Imaging 2018; 11:1036–1038.
Zhang Q, Burrage MK, Lukaschuk E, et al. Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy. Circulation 2021; 144:589–599.
van Smeden M, Heinze G, Van Calster B, et al. Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease. Eur Heart J 2022; 43:2921–2930.
D’Ancona G, Massussi M, Savardi M, et al. Deep learning to detect significant coronary artery disease from plain chest radiographs AI4CAD. Int J Cardiol 2023; 370:435–441.
Bujnowska-Fedak MM, Węgierek P. The impact of online health information on patient health behaviours and making decisions concerning health. Int J Environ Res Public Health 2020; 17:880.
Coorey GM, Neubeck L, Mulley J, Redfern J. Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: systematic review with meta-synthesis of quantitative and qualitative data. Eur J Prev Cardiol 2018; 25:505–521.
Geissbuhler A, Spahni S, Assimacopoulos A, Raetzo MA, Gobet G. Design of a patient-centered, multiinstitutional healthcare information network using peer-to-peer communication in a highly distributed architecture. Stud Health Technol Inform 2004; 107:1048–1052.
Geissbühler A. eHealth: easing translation in healthcare. Swiss Med Wkly 2012; 142:w13599.
Santo K, Redfern J. Digital health innovations to improve cardiovascular disease care. Curr Atheroscler Rep 2020; 22:71.